IRIS
BONDANZA, ATTILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.309
EU - Europa 3.897
NA - Nord America 3.091
SA - Sud America 1.211
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 91
OC - Oceania 12
Totale 12.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.922
RU - Federazione Russa 2.230
SG - Singapore 1.621
CN - Cina 1.302
BR - Brasile 981
SE - Svezia 580
HK - Hong Kong 525
VN - Vietnam 418
IT - Italia 377
FR - Francia 201
DE - Germania 140
AR - Argentina 96
BD - Bangladesh 90
IN - India 89
GB - Regno Unito 86
CA - Canada 76
JP - Giappone 58
EC - Ecuador 49
FI - Finlandia 48
AT - Austria 46
MX - Messico 45
NL - Olanda 40
ZA - Sudafrica 37
IE - Irlanda 36
ID - Indonesia 35
IQ - Iraq 35
CO - Colombia 24
PL - Polonia 23
PY - Paraguay 22
MA - Marocco 19
TR - Turchia 18
UA - Ucraina 16
ES - Italia 14
JM - Giamaica 14
UZ - Uzbekistan 14
IL - Israele 13
PK - Pakistan 12
SA - Arabia Saudita 12
VE - Venezuela 11
DZ - Algeria 10
CL - Cile 9
TN - Tunisia 9
UY - Uruguay 9
EG - Egitto 8
AU - Australia 7
IR - Iran 7
MY - Malesia 7
PE - Perù 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
KE - Kenya 6
LT - Lituania 6
CH - Svizzera 5
CR - Costa Rica 5
HU - Ungheria 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
PH - Filippine 5
PR - Porto Rico 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
JO - Giordania 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BB - Barbados 3
BE - Belgio 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
GR - Grecia 3
GT - Guatemala 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
BO - Bolivia 2
DK - Danimarca 2
HN - Honduras 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
RO - Romania 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
Totale 12.609
Salva come PNG Salva come JPEG
Città #
Singapore 581
Hong Kong 519
Moscow 513
Dallas 388
Ashburn 356
San Jose 352
Shanghai 255
Council Bluffs 199
Hefei 194
Lawrence 185
Princeton 185
Lauterbourg 161
Ho Chi Minh City 146
Beijing 145
New York 139
Milan 105
Hanoi 77
São Paulo 70
Santa Clara 55
Los Angeles 54
Nuremberg 38
Rio de Janeiro 38
Dublin 34
Phoenix 34
Boardman 29
Orem 27
Helsinki 26
Brooklyn 24
Chennai 23
Guangzhou 23
Tokyo 23
Da Nang 22
London 22
Munich 22
Belo Horizonte 21
Johannesburg 21
Quito 20
Seattle 20
Brasília 19
Guayaquil 18
Montreal 18
Warsaw 18
Haiphong 17
Vienna 17
Biên Hòa 16
The Dalles 16
Turku 16
Washington 16
Curitiba 15
Toronto 15
Boston 14
Rome 14
Mexico City 13
Campinas 12
Denver 12
Frankfurt am Main 12
Poplar 12
Porto Alegre 12
Tashkent 12
Baghdad 11
Naples 11
Can Tho 10
Chicago 10
Guarulhos 10
Hangzhou 10
Shenzhen 10
Shijiazhuang 10
Amsterdam 9
Ankara 9
Atlanta 9
Buenos Aires 9
Goiânia 9
Hải Dương 9
Salvador 9
Stockholm 9
Xi'an 9
Zhengzhou 9
Fortaleza 8
Jiaxing 8
Kingston 8
Manchester 8
Montevideo 8
Newark 8
Philadelphia 8
Recife 8
San Francisco 8
Bologna 7
Houston 7
Mumbai 7
Reston 7
Santo André 7
Tianjin 7
Volta Redonda 7
Asunción 6
Baku 6
Barnet 6
Bauru 6
Buffalo 6
Campos dos Goytacazes 6
Caxias do Sul 6
Totale 5.795
Salva come PNG Salva come JPEG
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 228
Loss of mismatched HLA in leukemia after stem-cell transplantation 219
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 216
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 179
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 178
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 173
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 163
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 147
Anti-beta 2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance 145
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 129
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 125
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 124
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 121
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 119
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 118
A dual role for genetically modified lymphocytes in cancer immunotherapy 116
null 112
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 111
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 110
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 107
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 103
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 101
Anti-beta 2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance 95
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 95
An apoptotic cell threshold for dendritic cell maturation and function. 95
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 94
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 93
Application of Donor Lymphocytes Expressing a Suicide Gene for Early GvL Induction and Later Control of GvH reactions after Bone Marrow Tranaplantation 92
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 92
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 89
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 87
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 85
Anti-phospholipid antibodies opsonize activated platelets for uptake by dendritic cells: relevance to epitope spreading in platelet autoimmunity. 85
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 85
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 84
Autoantibody Production during Chronic Graft-Versus-Host Disease Does Not Associate with Long-Term Persistence of Host B Cells in Humans 83
Apoptotic cell-pulsed dendritic cells break tolerance and accelerate lupus in NZB/W F1 mice. 83
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 82
B- and T-cell interactions in graft-versus-host disease 82
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 81
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 80
Stability of human rapamycin-expanded CD4(+)CD25(+) T regulatory cells 78
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 78
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors 77
The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer 77
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival 76
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 76
TNF-alpha coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens 74
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 74
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 73
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 73
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 71
Dual Transgenesis of T Cells with a CD44v6 CAR and a Suicide Gene for the Safe Eradication of Myeloid Leukemia and Myeloma 69
Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4(+) T Cells 69
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 69
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 68
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 68
T Cell Receptor Gene Transfer into Early Differentiated Lymphocytes by Lentiviral Vectors for Safe and Effective Adoptive Immune Therapy of Leukemia 67
CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer 66
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 65
H1N1 vaccination post-allogeneic haematopoietic stem cell transplantation and the risk of GvHD 65
Jon van Rood (1926-2017) 65
Use of IL-7 and IL-15 for the genetic modification of memory T lymphocytes 64
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells 64
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4(+) and CD8(+) T-cell responses 63
Improving the safety of cell therapy with the TK-suicide gene. 63
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation 63
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 63
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 62
Editing human lymphocytes specificity for safe and effective adoptive immunoterapy of leukemia 61
CD44v6 is associated with chemoresistance induced by bone marrow-derived mesenchymal stromal cells 61
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 61
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens 61
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 60
Clinical pharmacology of CAR-T cells: linking cellular pharmacodynamics to pharmacokinetics and antitumor effects 60
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies 60
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 60
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 60
Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia 59
Naive-Derived Memory Stem T Cells: A Novel Promising Platform for Cancer Immune-Gene Therapy 59
uPA/uPAR system is active in immature dendritic cells derived from CD14(+)CD34(+) precursors and is down-regulated upon maturation 59
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 58
Overcoming the toxicity hurdles of genetically targeted T cells. 58
Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia 58
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 57
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 56
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 56
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 56
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation 56
Immunostimulatory leukemic dendritic cells can efficiently expand leukemia-reactive T cells from HSCT donors 56
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression 56
Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients 55
Dual transgenesis of T-cells with a CD44v6 CAR and a suicide gene for the safe eradication of myeloid leukaemia and myeloma 55
Dual Transgenesis of T Cells with a Novel CD44v6-Specific Chimeric Antigen Receptor and a Suicide Gene for Safe and Effective Targeting of Chemoresistance in Hematopoietic Tumors 55
Haploidentical HSCT: a 15-year experience at San Raffaele. 55
Harnessing CD1-restricted T cells for the immunotherapy of leukemia 54
Modulation of graft-versus-host disease induced by central memory suicide gene modified human T lymphocytes 53
Progress and prospects: graft-versus-host disease 53
Gene transfer of modified idiotype into dendritic cells for immunotherapy of non-Hodgkin lymphomas 53
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 53
Totale 8.520
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 0 0 68 9 6 10 10 12 16 3 9
2022/20231.094 408 233 67 3 25 119 54 76 62 12 27 8
2023/2024567 26 22 49 52 50 114 59 51 8 30 22 84
2024/20252.647 306 30 34 113 71 186 309 218 477 373 258 272
2025/20267.670 582 626 718 1.231 511 222 604 523 1.993 327 171 162
2026/2027510 153 357 0 0 0 0 0 0 0 0 0 0
Totale 12.708